the joint commission © copyright, the joint commission the joint commission & the pharmacy...
Post on 21-Dec-2015
221 views
TRANSCRIPT
![Page 1: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/1.jpg)
The Joint Commission ©
Cop
yrig
ht, T
he J
oint
Com
mis
sion
The Joint Commission & the Pharmacy Buyer: Update for 2009
Darryl S. Rich, Pharm.D., M.B.A., FASHPSurveyor, The Joint Commission
![Page 2: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/2.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
Objectives Brief overview of the current Joint
Commission Accreditation and Survey Process.
Discuss major standards and national patient safety goals of relevance to purchasing managers.
![Page 3: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/3.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
Accreditation and Certification
Triennial (3 yr) on-site survey– Ad hoc off-cycle surveys
Annual Periodic Performance Reviews (PPR)
Continuous performance measurement requirements (Core Measures)
Sentinel Event Reporting/Review.
![Page 4: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/4.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
Core Measures Must collect data on each measure
in 4 selected core measure sets and report them to the Joint Commission quarterly
Must generate run or control charts on each measure quarterly and must analyze and improve if over three or more consecutive quarters for the same measure, identify the hospital as a negative outlier.
![Page 5: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/5.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
Sample Report
![Page 6: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/6.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
Core Measures
• Heart Attack Care (AMI)• Heart Failure (CHF)• Pneumonia• Critical Care• Children’s Asthma• Inpatient Psychiatric Services• Surgical Care (SCIP)• Venous Thromboembolism (VTE)• Stroke
![Page 7: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/7.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
Accreditation ProgramsHospitals and critical access hospitalsHome care services
– Pharmacies (home infusion, mail-order)– DMEPOS suppliers
Long term care servicesBehavioral health care servicesFreestanding ambulatory organizations Freestanding laboratories
![Page 8: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/8.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
Certification Programs
Disease Specific Care– Primary Stroke Center– Chronic Kidney Disease – COPD – Diabetes (Inpatient) – Transplant Center
CMS-programs– Lung Volume
Reduction Surgery– Ventricular Assist
Device
Healthcare Staffing
![Page 9: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/9.jpg)
The Joint Commission ©
Cop
yrig
ht, T
he J
oint
Com
mis
sion
The Survey Process
![Page 10: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/10.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
Some Important Points Accreditation evaluates if the appropriate
systems are in place to provide safe and effective healthcare.– Accreditation DOES NOT evaluate clinical practice
or medical care decisions. Only TJC standards surveyed – not others*. TJC standards specify what – not how. Focus is on patient safety and performance
improvement (CQI) Standards are optimal achievable – not minimum
or best practices.* Do survey applicable law and regulation.
![Page 11: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/11.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
Surveys
Unannounced Full Survey (18-39 months)Special Unannounced Survey for CauseRandom Validation SurveyExtension SurveyConditional Follow-up Survey
![Page 12: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/12.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
SurveyorsHospitals
– Physician, Nurse, Administrator– Engineer– Ambulatory Surveyor– As appropriate:
Home Care, Behavioral, Long Term Care
– CALS Survey
![Page 13: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/13.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
Survey Process Unannounced Tracer Methodology System Tracers
– Medication Management– Infection Control– Data Use – Environment of Care/Disaster Planning– Competence/Credentialing– Leadership
Priority Focus Process
![Page 14: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/14.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
Priority Focus Process
Clinical Service Groups– Selection of Tracer Patients
Priority Focus Areas– Selection of Priority Processes to
Review
– Identification of Relevant Standards
![Page 15: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/15.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
2009 SII: Standard Improvement Initiative
New numbering system (MM.01.02.04) Chapters reorganized alphabetically
– Some new chapters – EM, TS, WT, RC Some requirements eliminated/moved EP’s rewritten for clarity but nothing new
– Documentation & written policy/process identified
![Page 16: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/16.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
Medicare Deemed Status
Implications of the Medicare Improvements for Patients and Providers Act of 2008– TJC standards more closely aligned with
Medicare Conditions of Participation– TJC interpretation based on CMS
interpretation– CMS input into survey process changes– New EP’s based on language specificity in
COPEffective July 1, 2009
![Page 17: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/17.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
Manual Chapters– Accred. Participation
Requirements (APR)– Environment of Care (EC)– Emergency Management (EM)– Human Resources (HR)– Infection Prevention and Control
(IC)– Information Management (IM)– Leadership (LD)– Life Safety (LS)– Medication Management (MM)– Medical Staff (MS)
– National Patient Safety Goals (NPSG)
– Nursing (NR)– Provision of Care, Treatment &
Services (PC) – Performance Improvement (PI) – Record of Care, Treatment and
Service (RC)– Rights and Responsibilities of
the Individual (RI)– Transplant Safety (TS)– Waived Testing (WT)
Not Department Specific!
![Page 18: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/18.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
Standards
Standard Number (e.g. MM.04.01.02)
Standards Statement (not scored)
Rationale (not scored)
Elements of Performance (scored)
– Categories A (yes/no), C (frequency)– Direct Impact/Indirect Impact
![Page 19: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/19.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
ScoringRequirement for Improvement (RFI)
– Any Standard with an EP scored non-compliant or partially compliant.
– Direct vs. Indirect Impact
Surveyor only present report of findingsCentral Office determines accreditation
status based on findings– Minimum number of direct impact standard
scored required for central office review.
![Page 20: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/20.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
Normal Follow-up
Evidence of standards compliance (ESC) – 45 days after survey for each standard with direct
impact EP’s scored.– 60 days after survey for standards with only indirect
impact EP’s scored.– “Measure(s) of success” (MOS) for some.
Results posted on website (Quality Check). Six months after survey:
– Submit data on MOS over past 4 months.
![Page 21: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/21.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
Publicly Disclosed Decisions
AccreditationProvisional AccreditationConditional AccreditationPreliminary Denial of AccreditationDenial of AccreditationNot Accredited (never applied)
![Page 22: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/22.jpg)
The Joint Commission ©
Cop
yrig
ht, T
he J
oint
Com
mis
sion
Standardsand
National Patient Safety Goals
![Page 23: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/23.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
Top MM Standards ScoredNon-Compliant in 2008
MM.2.20 Medication Storage 37% MM.3.20 Medication Orders 16% MM.4.10 Pharmacist Review 5% MM.7.10 High Alert Medications 3% MM.4.30 Medication Labeling 3% MM.2.30 Emergency Meds 2%
all others 1% or less.
![Page 24: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/24.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
Top Med-related NPSG ScoredNon-Compliant in 2008
3D Med Labeling in Procedures25%
8A Admission Med Reconciliation 19% 8B Transfer/DC Med Reconciliation 12% 2B Unapproved Abbreviations 15% 3C: Look-Alike, Sound-Alike Drugs 4% 1A: Two patient identifiers
2%
![Page 25: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/25.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
MM.02.01.01 Medication Selection and Procurement
2008 Non-Compliance = <0.5%
Elements of Performance
1. Written criteria for formulary additions
2. Criteria, at minimum includes:– Effectiveness, drug interactions, potential for errors/abuse,
ADE, sentinel event advisories, other risks, costs.
3. Process to monitor pt. response to new drugs
4. Maintain formulary (incl. strength & dosage)
5. Formulary list is readily available
![Page 26: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/26.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
MM.02.01.01 (cont.)
Elements of Performance6. Standardize/limit number of available drug
concentrations7. Process for non-formulary medications 8. -- Implement this process 9. Formulary medications reviewed annually 10.Process to communicate medication
shortages to LIP/staff11.-- Implements this process
![Page 27: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/27.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
MM.02.01.01 (cont.)
Elements of Performance
12.Develops/approves medication substitution protocols for shortages/outages
13. -- Implement these substitution protocols
14.Communication process for substitution protocols to LIP/staff
15. -- Implements this communication process
![Page 28: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/28.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
MM.03.01.01 Safe Storage
2008 Non-compliance = 34.0%
#1 MM Non-compliance Issue - #4 among all standards.
EP 6. The hospital prevents unauthorized individuals from obtaining medications in accordance with its policy and law and regulation.– Medication Security
![Page 29: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/29.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
Medication Security
Revised Medicare Conditions of Participation – Federal Register 11/27/06, effective 1/28/07– All drugs and biologicals be kept in a secure
area, and locked when appropriate. – Schedules II, III, IV, and V drugs must be
kept locked within a secure area. – Only authorized personnel may have access
to locked areas, as defined in policy.
![Page 30: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/30.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
Medication Security L&D and ICUs considered secure if entry and exit
are limited to appropriate staff, patients & visitors
OR Suite is secure only if active and staffed
Due to mobility, mobile carts must be in a locked room or under constant surveillance.
Medications at bedside only if self-administered
Janitors, maintenance and other staff may have access ONLY if in organization policy
Revised Interpretive Guidelines for Hospital COP. CMS Memo S&C-08-12, February 8, 2008
![Page 31: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/31.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
MM.03.01.01 (cont.) No EP 1 EP 2. The hospital stores medications
according to the manufacturer’s recommendations or, if none, according to a pharmacist's instructions.– Refrigerator Temperatures
EP 3. The hospital stores controlled (scheduled) medications to prevent diversion, in accordance with law and regulation (DEA, state).
![Page 32: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/32.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
MM.03.01.01 (cont.) EP 4. Written policy addressing the
control of medication between receipt (removal from storage) by individual HCP (MD, RRT, RN ) and medication administration – including safe storage, handling, security,
disposition, and return to storage.
EP 5. The policy is implemented
![Page 33: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/33.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
MM.03.01.01 (cont.)
Elements of Performance7. Stored drugs and components of drugs are
labeled with contents, expiration date and appropriate warnings. Expiration date, not date opened
8. Removal & separate storage of expired, damaged, outdated medications
9. Storage and precautions for concentrated electrolytes
18.Periodic inspection of drug storage areas
![Page 34: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/34.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
Most Ready-to-Administer
MM.03.01.01, EP 10 – Floor stock medications
MM.05.01.11, EP 4 – Medications dispensed
– must be in the most ready-to administer form available from a manufacturer (unit dose, pre-filled syringes, premixed bags) either:Using the manufacturer’s product
Using the drug in that form repackaged by a licensed repackager.
Using the drug in that form prepared or repackaged by the pharmacy.
![Page 35: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/35.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
NPSG.03.05.01 Anticoagulation Management
EP 2: To reduce compounding and labeling errors, the hospital uses only oral unit dose products, pre-filled syringes, or pre-mixed infusion bags when these types of products are available.
– Note: For pediatric patients, pre-filled syringe products should only be used if specifically designed for children.
![Page 36: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/36.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
MM 03.01.03 Emergency Medications2008 Non Compliance = 3.4% (#4)Elements of Performance1. Medical staff decide which emergency
medications and supplies will be accessible Crash cart, Emergency Boxes/Kits
2. Emergency medications/supplies are accessible in patient care areas
3. Unit-dose, age-specific, & most ready-to-administer form available
6. Replacement of emergency medications and supplies as soon as possible.
![Page 37: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/37.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
MM.03.01.05 Medications Brought In
2008 Non Compliance = <0.5%
Elements of Performance
1. Defines when medications brought in by patient or MD can be administered
2. Prior to use, identification and visual evaluation of integrity
3. Inform prescriber/patient if medications brought in are not permitted
![Page 38: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/38.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
MM.05.01.07 Medication Preparation
2008 Non-Compliance = 2.5% (#6)
Elements of Performance
1. Pharmacy compounds/admixes all compounded sterile preparations, except: Urgent situations where delay could harm patient When the product’s stability is short.
Compounded product = 2+ drugs Admixture = addition of drug to <50ml bag/bottle. Exception: Closed transfer system Does not apply to reconstitution
![Page 39: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/39.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
MM.05.01.07 (cont.)
Elements of Performance
2. Use of clean/sterile techniques and clean, uncluttered, and functionally separate area for preparation.
3. Staff visually inspect medication for particulates, discoloration, or loss of integrity
4. Laminar airflow hood/ISO Class 5 environment in pharmacy and where product will not be used within 24 hours.
A Word About USP 797
![Page 40: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/40.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
New COP Related EP
MM.05.01.07 Medication Preparation– EP 6: In-house preparation of
radiopharmaceuticals is done by, or under the supervision of, an appropriately trained registered pharmacist or doctor of medicine or osteopathy.
![Page 41: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/41.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
MM.05.01.09 Medication Labeling
2008 Non-compliance = 2.8% (#5)Elements of Performance 1. Medication containers are labeled whenever
medications are prepared but not immediately administered
– An immediately administered medication is one that is prepared or obtained, taken directly to a patient, and administered to that patient without any break in the process.
2. Label information in standardized format
![Page 42: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/42.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
MM.05.01.09 (cont.)
Medication name, strength, amount
Expiration date (when used >24 hrs)
Expiration time (if <24 hours)
For compounded IV admixtures and TPN: Date prepared and
diluent used
• When preparing individualized meds for multiple patients OR when medication is prepared by someone other than person administering it: Patients name Location where medication
is to be delivered Directions for use,
accessory and cautionary instructions
![Page 43: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/43.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
Medication Labeling NPSG
NPSG 03.04.01: Label all medications and solutions on and off the sterile field (25%)– All medications and solutions labeled.– Name, strength, etc.– Actual containers labeled.– Must be labeled immediately before or
after transfer as part of same process.Use of pre-labeled containers or syringes
not acceptablePreprinted labels OK
![Page 44: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/44.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
MM.05.01.13 Medication After Hours
2008 Non-compliance = <0.5%Elements of Performance1. Process for providing medications when
pharmacy is closedWhen non-pharmacist health care professionals
obtain medications after pharmacy closed:2. Medications limited3. Medications stored/secured outside
pharmacy
![Page 45: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/45.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
MM.05.01.13 (cont.)
Elements of Performance4. Only designated prescribers/nurses have
access to limited supply (never to pharmacy)5. Quality control measures are used to
prevent medication retrieval errors6. Pharmacist available on-call or at another
location to answer questions and access pharmacy after-hours.
7. Implements process
![Page 46: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/46.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
MM.05.01.17 Recalled, Discontinued Medications
2008 Non-compliance = 0.6%
Elements of Performance
1. Written policy for retrieval/handling recalled and discontinued medications by mfgr/FDA
2. Implements policy
3. When drug recalled/discontinued, notifies those who prescribe, dispense, administer
4. Inform patients when their medications are recalled and discontinued.
![Page 47: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/47.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
MM.05.01.19 Returned Medications
2008 Non-compliance = <0.6%
Elements of Performance
1. Determines under what circumstances unused, expired, or returned medication will be managed by the pharmacy or hospital
2. Process for returning medications to pharmacy’s control
3. When outside sources used for destruction
4. Implements process
![Page 48: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/48.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
MM.06.01.05 Investigational Medications
2008 Non-compliance = <0.5%
Elements of Performance
Written process:
1. Use of investigational medications– review, approval, supervision, and monitoring.
2. Specifies pharmacy controls storage, dispensing, labeling, and distribution
3. Accommodates continued participation
4. Processes implemented
![Page 49: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/49.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
EC.02.02.01 Hazardous Material
2008 Non-compliance = 1%
Elements of Performance1. The hospital maintains a written, current inventory of
hazardous materials and waste that it uses, stores, or generates.
The only materials that need to be included on the inventory are those whose handling, use, and storage are addressed by law and regulation.
3. Has written procedures (including precautions, PPE) to follow in response to hazardous material and waste spills or exposures.
4. Procedures are implemented
![Page 50: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/50.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
Hazardous Medications
EC.02.02.01 8. Minimizes risks associated with disposing
hazardous medications.
11. Has all hazardous material and waste permits, licenses, manifests, and MSDS required by law and regulation.
MM.01.01.034. Minimizes risks associated with managing
hazardous medications.
![Page 51: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/51.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
Emergency Management
EM.01.01.01– The hospital keeps a documented
inventory of the resources and assets it has on site that may be needed during an emergency, including… medication-related resources and assets.
![Page 52: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/52.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
Emergency Operations Plan
EM.02.01.01– Addresses preparedness, mitigation,
response and recovery.– Identifies the hospital’s capabilities and
establishes response procedures for when the hospital cannot be supported by the local community for at least 96 hours.
![Page 53: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/53.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
Emergency Operations Plan
EM.02.02.01
Emergency Operations Plan addresses– How the hospital will communicate with
purveyors of essential supplies, services, and equipment during an emergency.
![Page 54: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/54.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
Emergency Operations Plan
EM.02.02.03
Emergency Operations Plan addresses1. How the hospital will obtain and replenish
medications and related supplies required throughout the emergency & recovery from it.
– Including access to and distribution of caches that may be stockpiled by the hospital, its affiliates, or local, state, or federal sources.
2. Medical Supplies
3. Non-medical Supplies
![Page 55: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/55.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
EM.02.02.03 (con’t)
Emergency Operations Plan addresses4. How it will share resources and assets with other
health care organizations within the community, if necessary.
5. -- and outside the community in the event of a regional or prolonged disaster.
6. How it will monitor quantities of its resources and assets during an emergency.
9. Arrangements for transporting some or all patients, their medications, supplies, equipment, and staff to an alternative care site, if necessary.
![Page 56: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/56.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
EOP Implementation
EM.02.02.0312. The hospital implements the components of its
Emergency Operations Plan that require advance preparation to provide for resources and assets during an emergency.
EM.03.01.01 Documented annual review of its inventory list.
EM.03.01.03 Implements its EOP (real or drill) twice a year (not table-top).
![Page 57: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/57.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
NPSG 02.02.01 Do Not Use Abbreviations 2008 Non-compliance = 18.3% QD, QOD, U, IU, MS, MgSO4, MS04, Leading decimal, trailing zero Computer entries, preprinted forms.
![Page 58: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/58.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
NPSG 03.03.01 LASA Drugs
2008 Noncompliance = 5% (#9 tied)
Elements of Performance The hospital identifies a list of look-alike/sound-alike
medications used by the hospital. The hospital reviews the list of look-alike/sound-alike
medications at least annually. The hospital takes action to prevent errors involving
the interchange of the medications on the list of look-alike/sound-alike medication list.
![Page 59: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/59.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
NPSG 03.03.01 (cont.)Top Compliance Issue
– Not following own policye.g. insulin not segregated in unit refrigerators
– Most organizations not implementing effective actions – most errors in past year have been related to LASA issues.
![Page 60: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/60.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
Other StandardsIM.03.01.01
– Knowledge based information are up-to-date and available.
![Page 61: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/61.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
For Further Information
www.jointcommission.org– FAQ for current standards– FAQ for current NPSG– Copy of 2009 NPSG – Current and Past Copies of:
Sentinel Event Alert Joint Commission Online
– Pre-publication Standards
Current Standards (CAMH) and Perspectives must be obtained from hospital TJC coordinator
![Page 62: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/62.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
Questions
For questions about the interpretation of Joint Commission standards, organizations (or the public) can submit their questions by either: – Calling the Standards Interpretation Unit at 630-
792-5900– Submitting the question in writing by using the
following on-line form: http://www.jointcommission.org/Standards/OnlineQuestionForm/
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
![Page 63: The Joint Commission © Copyright, The Joint Commission The Joint Commission & the Pharmacy Buyer: Update for 2009 Darryl S. Rich, Pharm.D., M.B.A., FASHP](https://reader030.vdocuments.us/reader030/viewer/2022032704/56649d615503460f94a437c5/html5/thumbnails/63.jpg)
© C
opyr
ight
, The
Joi
nt C
omm
issi
on
The Joint Commission
DisclaimerThis presentation is current as of June 21, 2009. The
Joint Commission reserves the right to change the content of the information, as appropriate.
These slides are only meant to be cue points, which were expounded upon verbally by the original presenter and are not meant to be comprehensive statements of standards interpretation or represent all the content of the presentation. Thus, care should be exercised in interpreting Joint Commission requirements based solely on the content of these slides.
These slides are copyrighted and may not be further used, shared or distributed without permission of the original presenter or the Joint Commission
© C
opyr
ight
, The
Joi
nt C
omm
issi
on